Skip to main content

Table 3 Antibiotic resistance in Gram-negative isolates

From: The incidence, risk factors and outcomes of early bloodstream infection in patients with malignant hematologic disease after unrelated cord blood transplantation: a retrospective study

Antibiotics Escherichia coli,% (n = 39) Klebsiella pneumoniae, % (n = 9) Pseudomonas aeruginosa, % (n = 6) MDR bacteria, % (n = 37)
Amikacin 12.8 44.4 0 18.9
Ampicillin 100 100 33.3 100
Aztreonam 89.7 88.9 50 91.9
Ceftazidine 76.9 100 0 100
Ciprofloxacin 69.2 66.7 0 91.9
Ceftriaxone 100 100 33.3 100
Cefepime 82.1 100 0 100
Gentamicin 74.4 77.8 0 81.1
Imipenem 5.1 33.3 0 13.5
Levofloxacin 64.1 55.6 0 75.7
Ampicillin-Sulbactam 97.4 100 33.3 100
Compound Sulfamethoxazole 87.2 100 33.3 100
Piperacillin 15.4 0 0 16.2